Keywords: Phytopharm, Myogane, Glaucoma, TSB grant

Phytopharm gets TSB grant to support development of Myogane in glaucoma

Article | 04 October 2011

Print This

UK-based Phytopharm (LSE: PYM) has been awarded a grant by the Technology Strategy Board to provide funding to support the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in